BioMarin (BMRN) Announces Completion of Enrollment for Phase 3 Study on GALNS
Go back to BioMarin (BMRN) Announces Completion of Enrollment for Phase 3 Study on GALNS| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.53 -0.7 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.23 | 52 Week High | $108.96 | |||
| Open | $65.54 | 52 Week Low | $62.12 | |||
| Day High | $66.02 | P/E | N/A | |||
| Day Low | $64.49 | EPS | $-1.27 | |||
| Volume | 995,074 | |||||
